l glutathion reduit 50 mg L-glutathion réduit 300 Solgar L-Glutathion Réduit 50 mg
Description
Prevention of hepatocellular carcinoma: Focusing on antioxidant therapy

Axoltis Pharma presents promising results from phase 1B clinical trial of innovative drug candidate for neurodegenerative diseases

Sanyal, Morten A

Best Pract Res Clin Gastroenterol [Internet]

(February 1997)
